A long-term therapeutic experience with Cernilton in chronic prostatitis
Jodai A, Maruta N, Shimomae E, Sakuragi T, Shindo K, Saito Y
Thirty-two patients with chronic prostatitis were given 6 tables of Cernilton
daily for 12.6 weeks on the average. Improvement of subjective symptoms and
objective findings was noted in 74.2% and 65.6% of the cases, respectively. The
effective rate was 75.0%. No subjective symptoms or abnormal changes in
laboratory data were observed in any case after Cernilton medication.
PMID: 3389296, UI: 88267078
Department of Urology
Nagasaki University School of Medicine